Pomalyst Approved for Advanced Multiple Myeloma
New Drugs , News / October 2, 2016

The FDA approved Pomalyst (pomalidomide) for the treatment of multiple myeloma patients whose disease progressed after being treated with other cancer drugs. Multiple myeloma is a form of blood cancer that primarily affects older adults and arises...

Skip to toolbar